Coloplast As Sp/Adr (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,964 | 98,675 | 71,994 | 72,459 | 67,758 |
| Marketable Securities | 33,176 | 34,121 | 36,318 | 36,959 | 41,660 |
| Receivables | 651,607 | 575,145 | 597,804 | 585,019 | 577,562 |
| Inventories | 432,796 | 383,789 | 390,180 | 385,474 | 371,047 |
| TOTAL | $1,231,885 | $1,119,551 | $1,123,936 | $1,106,657 | $1,087,205 |
| Non-Current Assets | |||||
| PPE Net | 636,376 | 590,977 | 608,250 | 593,286 | 578,535 |
| Investments And Advances | 6,183 | 6,302 | 6,589 | 4,053 | 4,053 |
| Intangibles | 3,196,809 | 565,155 | 586,716 | 589,071 | 585,829 |
| Other Non-Current Assets | 232,383 | 206,112 | 220,159 | 212,675 | 216,241 |
| TOTAL | $4,071,751 | $1,368,545 | $1,421,713 | $1,399,085 | $1,384,658 |
| Total Assets | $5,303,636 | $2,488,096 | $2,545,649 | $2,505,742 | $2,471,863 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 421,938 | 468,478 | 462,173 | 389,040 | 361,969 |
| Other current liabilities | 3,178,412 | 707,174 | 374,913 | 624,896 | 596,042 |
| TOTAL | $3,741,499 | $1,302,915 | $1,014,660 | $1,153,504 | $1,105,846 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 465,369 | 198,580 | 218,391 | 229,372 | 241,691 |
| TOTAL | $465,369 | $198,580 | $218,391 | $229,372 | $241,691 |
| Total Liabilities | $4,206,868 | $1,501,495 | $1,233,051 | $1,382,875 | $1,347,537 |
| Shareholders' Equity | |||||
| Common Shares | 32,573 | 33,199 | 34,711 | 35,014 | 35,014 |
| Retained earnings | 932,246 | 1,024,872 | 868,744 | 1,152,693 | 985,568 |
| Other shareholders' equity | 131,950 | -71,471 | 409,143 | -64,840 | 103,744 |
| TOTAL | $1,096,768 | $986,600 | $1,312,598 | $1,122,867 | $1,124,326 |
| Total Liabilities And Equity | $5,303,636 | $2,488,095 | $2,545,649 | $2,505,742 | $2,471,863 |